SBTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Silverback Therapeutics, Inc. Is Fair to Shareholders

Author's Avatar
Jul 21, 2022

Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Silverback Therapeutics, Inc. (NASDAQ: SBTX) and ARS Pharmaceuticals, Inc. is fair to Silverback shareholders. Under the terms of the merger agreement, assuming that Silverback’s net cash at closing is $240 million, Silverback equity holders are expected to own approximately 37% of the combined company.